Date published: 2025-11-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

C18orf16 Inhibitors

C18orf16, or Chromosome 18 Open Reading Frame 16, is a gene located on the 18th chromosome in humans. Its precise locus is defined as 18q21.2, which means it is situated on the long arm of chromosome 18 in region 2, band 1, sub-band 2. The protein encoded by the C18orf16 gene is a member of the human proteome, but as with many open reading frames identified through genome sequencing projects, it may be relatively uncharacterized in terms of its biological functions and interactions.Research into C18orf16 and its encoded protein has yet to fully uncover its roles within cellular processes. However, the designation "orf" suggests that the region was initially identified as part of genomic annotation efforts and may have been recognized due to its potential to encode a protein based on its sequence motifs and predicted structure rather than through empirical protein function characterization.

The C18orf16 protein could be involved in a variety of cellular activities, ranging from regulation of gene expression, protein-protein interactions, metabolic processes, or even cell signaling pathways. As with many proteins of uncertain function, it may interact with other proteins or cellular components, and these interactions can help to elucidate its role in cellular physiology.Further experimental studies, including gene expression analysis, protein interaction assays, and functional characterization studies, are needed to reveal the significance of C18orf16 in human biology. Its expression pattern across tissues, response to different cellular stimuli, and potential involvement in disease states or developmental processes remain areas of active investigation.

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Wortmannin

19545-26-7sc-3505
sc-3505A
sc-3505B
1 mg
5 mg
20 mg
$66.00
$219.00
$417.00
97
(3)

A potent inhibitor of phosphoinositide 3-kinases (PI3K), which could affect pathways that C18orf16 is involved in.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$121.00
$392.00
148
(1)

Another PI3K inhibitor, which may indirectly influence C18orf16-related pathways.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$62.00
$155.00
$320.00
233
(4)

Inhibits mTOR, a key kinase in many signaling pathways, potentially impacting C18orf16's function.

SB 203580

152121-47-6sc-3533
sc-3533A
1 mg
5 mg
$88.00
$342.00
284
(5)

Targets p38 MAP kinase, potentially affecting pathways involving C18orf16.

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$39.00
$90.00
212
(2)

A selective inhibitor of MEK, which may indirectly influence C18orf16 function through MAPK signaling.

SP600125

129-56-6sc-200635
sc-200635A
10 mg
50 mg
$40.00
$150.00
257
(3)

An inhibitor of JNK, which may alter pathways connected to C18orf16.

BML-275

866405-64-3sc-200689
sc-200689A
5 mg
25 mg
$94.00
$348.00
69
(1)

Inhibits BMP signaling, which could be relevant to C18orf16's pathway interactions.

Y-27632, free base

146986-50-7sc-3536
sc-3536A
5 mg
50 mg
$182.00
$693.00
88
(1)

A ROCK inhibitor, potentially affecting cytoskeletal dynamics related to C18orf16.

Bafilomycin A1

88899-55-2sc-201550
sc-201550A
sc-201550B
sc-201550C
100 µg
1 mg
5 mg
10 mg
$96.00
$250.00
$750.00
$1428.00
280
(6)

A V-ATPase inhibitor, which could indirectly affect C18orf16's cellular context.

Thapsigargin

67526-95-8sc-24017
sc-24017A
1 mg
5 mg
$94.00
$349.00
114
(2)

An ER stress inducer, potentially influencing C18orf16-related pathways.